Results 161 to 170 of about 7,533,094 (293)
From Integrated Care to Learning Systems. [PDF]
Tsitiridis A +3 more
europepmc +1 more source
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault +12 more
wiley +1 more source
A Scoping Review of Integrated Care Models for Managing Depression in Older Adults. [PDF]
Haddad M +4 more
europepmc +1 more source
We established the avian chorioallantoic membrane (CAM) assay as a scalable in vivo model for studying circulating tumor cells (CTCs). Human gastrointestinal tumors spontaneously released genetically validated CTCs that were detected across multiple platforms, demonstrating that the CAM model provides an accessible tool for investigating early cancer ...
Dennis Roth +17 more
wiley +1 more source
Alberta family integrated care<sup>TM</sup>: a review of a family-integrated care model in neonatal intensive care. [PDF]
Wang S +6 more
europepmc +1 more source
Integrated care pathways: a new approach for integrated care systems
Christina van der Feltz-Cornelis +4 more
openaire +2 more sources
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim +17 more
wiley +1 more source
Correction: Navigating a Decade of Integrated Care Research in the International Journal of Integrated Care: How Far Have We Come? [PDF]
Michgelsen J +8 more
europepmc +1 more source
Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba +5 more
wiley +1 more source

